Clinical Trial Update: Description of Compliance With Hydroxychloroquine Treatment in Patients With Systemic Lupus Erythematosus

View source ↗

Summary

A completed clinical trial update describes how well patients with systemic lupus erythematosus adhered to hydroxychloroquine therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Lupus Erythematosus | Status: COMPLETED